Anchiano Therapeutics Ltd.Information Rights Agreement • January 13th, 2021 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
Contract Type FiledJanuary 13th, 2021 Company IndustryThis letter confirms our agreement and undertaking that subject to and following the initial public offering of American Depositary Receipts representing ordinary shares of Anchiano Therapeutics Ltd. (the “Company”) on the Nasdaq Global Market, Clal Biotechnology Industries Ltd. (the “Shareholder”) shall be entitled to the information rights set forth in this letter agreement (this “Agreement”), subject to the terms set forth herein.
Anchiano Therapeutics Ltd.Information Rights Agreement • January 7th, 2019 • Anchiano Therapeutics Ltd. • Pharmaceutical preparations
Contract Type FiledJanuary 7th, 2019 Company IndustryThis letter confirms our agreement and undertaking that subject to and following the initial public offering of American Depositary Receipts representing ordinary shares of Anchiano Therapeutics Ltd. (the “Company”) on the Nasdaq Global Market, Clal Biotechnology Industries Ltd. (the “Shareholder”) shall be entitled to the information rights set forth in this letter agreement (this “Agreement”), subject to the terms set forth herein.